2014
DOI: 10.1155/2014/598670
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Tight Junction Protein Claudin-1 in Human Crescentic Glomerulonephritis

Abstract: The origin of crescent forming cells in human glomerulonephritis (GN) remains unknown. Some animal studies demonstrated that parietal epithelial cells of Bowman's capsule (PECs) were the main component of proliferating cells and PEC-specific tight junction protein claudin-1 was expressed in crescentic lesions. We investigated the expression of claudin-1 in human GN. Immunohistochemistry for claudin-1 was performed on 17 kidney biopsy samples with crescent formation. Colocalization of claudin-1 with intracellul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 30 publications
0
7
0
Order By: Relevance
“…The claudin-1 antibody was raised against a synthetic peptide within human claudin-1 aa 150 to the C-terminus. The ab15098 antibody was used for targeting peripheral nerve perineurium ( Cohnen et al, 2020 ), as well as for applications of IHC of many other paraffin-embedded tissues [e.g., skin ( Kim et al, 2016 ), intestine ( Gumber et al, 2014 ; Mandle et al, 2019 ), and kidney ( Koda et al, 2014 )]; other claudin-1 antibodies were also used to label perineurium in peripheral nerves ( Pummi et al, 2004 ; Rittner et al, 2012 ; Piña et al, 2015 ; Reinhold et al, 2018 ).…”
Section: Methodsmentioning
confidence: 99%
“…The claudin-1 antibody was raised against a synthetic peptide within human claudin-1 aa 150 to the C-terminus. The ab15098 antibody was used for targeting peripheral nerve perineurium ( Cohnen et al, 2020 ), as well as for applications of IHC of many other paraffin-embedded tissues [e.g., skin ( Kim et al, 2016 ), intestine ( Gumber et al, 2014 ; Mandle et al, 2019 ), and kidney ( Koda et al, 2014 )]; other claudin-1 antibodies were also used to label perineurium in peripheral nerves ( Pummi et al, 2004 ; Rittner et al, 2012 ; Piña et al, 2015 ; Reinhold et al, 2018 ).…”
Section: Methodsmentioning
confidence: 99%
“…Nevertheless, their exciting results encourage further investigation of SIRT1 and claudin-1 as therapeutic targets of DN. Furthermore, there was also a study suggesting that claudin-1 contributed to crescent formation in crescentic glomerulonephritis (30). Thus, future studies are needed to investigate whether SIRT1, as a negative regulator of claudin-1, can serve as a potential target to prevent or treat crescentic glomerulonephritis.…”
Section: Sirt1 Preserves Podocyte Function By Targeting Claudin-1mentioning
confidence: 99%
“…14 Other groups have also described the use of formaldehyde fixation for claudin 1 18 and E-cadherin 19 immunofluorescence in breast cancer cells. In other cell models, formaldehyde or alcohol-based fixatives (including methanol) have alternatively been used for the immunofluorescence detection of claudin 1 18,20,21 or E-cadherin. 22,23 Interestingly, the direct comparison of different fixing protocols including formaldehyde and methanol fixation for the detection of claudin 1 in airway epithelial cells concluded that methanol fixation was optimal to obtain consistent and reliable signals.…”
Section: Discussionmentioning
confidence: 99%